rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1998-12-2
|
pubmed:abstractText |
Vesnarinone has yielded controversial results on morbidity in patients with congestive heart failure. We tested the hypothesis that vesnarinone may have a beneficial effect on cardiac remodeling and function.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0002-8703
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
136
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
769-77
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9812070-Aged,
pubmed-meshheading:9812070-Cardiotonic Agents,
pubmed-meshheading:9812070-Echocardiography,
pubmed-meshheading:9812070-Female,
pubmed-meshheading:9812070-Heart Failure,
pubmed-meshheading:9812070-Hemodynamics,
pubmed-meshheading:9812070-Humans,
pubmed-meshheading:9812070-Male,
pubmed-meshheading:9812070-Middle Aged,
pubmed-meshheading:9812070-Quinolines,
pubmed-meshheading:9812070-Ventricular Function, Left
|
pubmed:year |
1998
|
pubmed:articleTitle |
Effect of vesnarinone on cardiac function in patients with severe congestive heart failure.
|
pubmed:affiliation |
Cardiac Unit, Massachusetts General Hospital and Harvard Medical School, Boston 02114-2698, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|